Download DNB 2019 June GASTROENTEROLOGY GASTROENTEROLOGY PAPER 2 Question Paper

Download Diplomate in National Board (DNB) 2019 June GASTROENTEROLOGY GASTROENTEROLOGY PAPER 2 Previous Question Papers

FINAL EXAM
JUNE 2019
Time: 3 hours
NATIONAL BOARD OF EXAMINATIONS
GASTROENTEROLOGY
PAPER-II
Max. Marksz100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/f/owcharts wherever appropriate.
Write short notes on:
1 .
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.
a)
b)
0)
Tropical malabsorption syndrome.
Pathophysiology of short bowel syndrome.
HIV enteropathy
Acute on chronic liver failure(ACLF):
a)
b)
0)
Definition and Classification.
Etiopathogenesis.
Management.
NASH:
8)
b)
c)
a)
b)
a)
b)
c)
a)
b)
0)
Epidemiological spectrum.
Pathogenesis.
Management beyond life style modifications.
Recent advances in pathogenesis & diagnosis of
inflammatory bowel disease (IBD).
Newer therapies in IBD.
Molecular and genetic basis in pancreatic disorders.
Prognostic criteria in severe acute pancreatitis.
Autoimmune pancreatitis.
Approach to a case of incidentally detected HBsAg
positive subject.
Treatment of chronic Hepatitis B and C co-infection.
Treatment goals in Chronic Hepatitis B.
Pathogenesis of ascites in cirrhosis.
Diagnosis & management of spontaneous bacterial
peritonitis.
Management of refractory ascites.
-1.
GASTRO/J/19/10/Il
4+3+3
3+4+3
3+4+3
5+5
3+3+4
3+3+4
3+4+3
P.T.O.

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2019
GASTROENTEROLOGY
PAPER-II
8. Hepatocellular Carcinoma (HCC): 3+4+3
a) Molecular & genetic basis in pathogenesis.
b) Management strategies for early HCC.
c) Liver transplantation in HCC - When and Why?
9. a) Pathogenesis and prognostic scores in Severe 4+3+3
Alcoholic Hepatitis(SAH).
b) Status of liver transplant in SAH.
0) Non transplant management of SAH.
10. a) Management of primary sclerosing cholangitis. 4+3+3
b) |G4 cholangiopathy.
0) Clinical presentations of portal biliopathy.
***************
-2.
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.